Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome
Latest Information Update: 22 Nov 2023
At a glance
- Drugs Naltrexone (Primary)
- Indications Complex regional pain syndromes
- Focus Therapeutic Use
- 15 Nov 2023 Planned number of patients changed from 40 to 120.
- 22 Sep 2023 Planned End Date changed from 1 Jun 2023 to 1 Jun 2025.
- 22 Sep 2023 Planned primary completion date changed from 1 Jun 2023 to 1 Jun 2025.